Hypertrophic Cardiomyopathy Is Associated with Altered Left Ventricular 3D Blood Flow Dynamics

Judith T Pruijssen1, Bradley D Allen1, Alex J Barker1

  • 1Department of Biomedical Engineering and Physics (J.T.P.) and Department of Radiology & Nuclear Medicine (P.v.O.), Academic Medical Center, Amsterdam University Medical Centers, Location AMC, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands; Department of Radiology (B.D.A., J.C.C., M.M.), Department of Medicine-Cardiology (R.O.B., L.C.), and Department of Biomedical Engineering (M.M.), Northwestern University, Chicago, Ill; and Department of Radiology & Bioengineering, Children's Hospital Colorado, University of Colorado Anschutz Medical Campus, Denver, Colo (A.J.B.).

Insights

Four-dimensional flow MRI quantifies elevated velocity volumes (EVV) in hypertrophic cardiomyopathy (HCM) patients, revealing associations with systolic anterior motion (SAM) and mitral regurgitation (MR). This technique offers insights into HCM

Area of Science:

  • Cardiovascular Imaging
  • Biomedical Engineering
  • Medical Physics

Background:

  • Hypertrophic cardiomyopathy (HCM) is a complex heart muscle disease.
  • Understanding the hemodynamic alterations in HCM is crucial for patient management.
  • Systolic anterior motion (SAM) and mitral regurgitation (MR) are common complications in HCM.

Purpose of the Study:

  • To investigate the association between hemodynamic parameters and clinical manifestations in HCM using 4D flow MRI.
  • To quantify elevated velocity volumes (EVV) in the left ventricle (LV) of HCM patients.
  • To correlate EVV with SAM, MR, stroke volume, and cardiac mass.

Main Methods:

  • 13 patients with HCM and 11 healthy controls underwent 4D flow MRI.
  • Left ventricular (LV) velocity maps were analyzed to calculate EVV.
  • Standard cine imaging assessed SAM, MR, stroke volume, and cardiac mass.

Main Results:

  • Systolic EVV in HCM patients was significantly associated with elevated aortic peak velocity, decreased LV outflow tract diameter, and increased cardiac mass.
  • EVV was significantly higher in patients with SAM and MR compared to those without.
  • Diastolic LV velocity correlated with septal thickness.

Conclusions:

  • Quantification and visualization of EVV in the LV are feasible using 4D flow MRI.
  • EVV may provide valuable insights into the altered hemodynamics and clinical manifestations of HCM.
  • 4D flow MRI is a promising tool for evaluating HCM patients.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
126
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
170
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
131
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
127
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
147
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.8K